Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Immune Microenvironment”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Not applicableLooking for participantsNCT07100405
What this trial is testing

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

Who this might be right for
Hepatocellular Carcinoma
Fudan University 50
Testing effectiveness (Phase 2)UnknownNCT03844763
What this trial is testing

Targeting the Tumor Microenvironment in R/M SCCHN

Who this might be right for
Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest 71
Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Not applicableWithdrawnNCT02599909
What this trial is testing

Gut Microbiota in People With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Cell Caricinoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Not applicableUnknownNCT05677724
What this trial is testing

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

Who this might be right for
HBVPrimary Liver Cancer
Fubing Wang 20
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Not applicableEnded earlyNCT04875871
What this trial is testing

Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors

Who this might be right for
Cancer
EBG MedAustron GmbH 13
Not applicableStudy completedNCT07528911
What this trial is testing

Elements of Adaptive Immunity in Epithelial Ovarian Cancer

Who this might be right for
Epithelial High Grade Serous Ovarian Cancer
Hellenic Cooperative Oncology Group 687
Not applicableUnknownNCT03846856
What this trial is testing

The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

Who this might be right for
Ovarian Cancer
Hillel Yaffe Medical Center 40
Not applicableUnknownNCT05821790
What this trial is testing

Role of the Tumor Microenvironment in Aggressive Meningiomas

Who this might be right for
Meningioma
Assistance Publique - Hôpitaux de Paris 40
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Not applicableUnknownNCT05515133
What this trial is testing

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 60
Not applicableEnrolling By InvitationNCT04488614
What this trial is testing

Prospective Breast Cancer Biobanking

Who this might be right for
Breast Cancer
Helse Stavanger HF 1,200
Not applicableLooking for participantsNCT06144762
What this trial is testing

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 150
Not applicableUnknownNCT06154317
What this trial is testing

Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)

Who this might be right for
Multiple Myeloma
Centro di Riferimento Oncologico - Aviano 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04954339
What this trial is testing

DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab

Who this might be right for
Hepatocellular Carcinoma
Tae Won Kim 40
Not applicableLooking for participantsNCT04622423
What this trial is testing

Advanced Therapies for Liver Metastases

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Liver Metastasis+1 more
IRCCS San Raffaele 625
Not applicableStudy completedNCT06484127
What this trial is testing

Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study

Who this might be right for
Prostate Cancer
Fudan University 200
Load More Results